“…Guinea pig anti-porcine insulin serum was a gift from H. Kobayashi (Gunma University). The following commercially purchased antibodies were also used: rabbit polyclonal antibodies toward FLAG (F7425, Sigma-Aldrich, St. Louis, MO; RRID:AB_439687), myosin-Va (LF-18, Sigma-Aldrich; RRID:AB_260545), RIM-BP2 (15716–1-AP, Proteintech, Rosemont, IL), Munc13-1 (55053–1-AP, Proteintech), HA (561, MBL, Nagoya, Japan; RRID:AB_591839), green fluorescent protein (GFP; 598; MBL; RRID:AB_2313843), Rab27a/b (18975; IBL, Fujioka, Japan; RRID:AB_494635), PKA (ab26322; Abcam, Cambridge, United Kingdom), myosin-VIIa (ab3481; Abcam; RRID:AB_303841), Ca v 1.3 (ACC-005; Alomone Labs, Jerusalem, Israel; RRID:AB_2039775), RIM1/2 (140203; Synaptic Systems, Goettingen, Germany), and VAMP2 (627724; Calbiochem, San Diego, CA; RRID:AB_212589); and mouse monoclonal antibodies toward glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 3H12; MBL), α-tubulin (T5168; Sigma-Aldrich; RRID:AB_477579), β-actin (A5316; Sigma-Aldrich; RRID:AB_476743), syntaxin1 (HPC-1; Sigma-Aldrich; RRID:AB_592786), Na + -K + ATPase (C464.6; Upstate Biotechnology, Lake Placid, NY; RRID:AB_309699), Sec6 (ADI-VAM-SV021; Assay Designs, Ann Arbor, MI), and SNAP25 (610366; BD Biosciences; RRID:AB_397752) Tissue extract preparation, immunoblotting, and immunoprecipitation were performed as described previously (Matsunaga et al, 2017). Each image resulting from immunoblotting is representative of at least three independent experiments.…”